Global contraceptive drugs and devices market to reach $75b by 2035

Thanks to a rising awareness about family access.

The global contraceptive drugs and devices market is expected to reach $75b by 2035 at a compound annual growth rate of 4.31%, according to a Market Research Future report.

The sector’s expansion is attributed to a rising awareness about family access, growing access to healthcare services, and continuous developments in contraceptive technology.

“The contraceptive drugs and devices market spans a diverse range of products, from hormonal contraceptives and intrauterine devices to innovative non-hormonal options designed to meet varying consumer needs,” the report said.

Meanwhile, partnerships between government and private healthcare providers are contributing to a growing demand for reproductive health products across both developed and emerging markets.

“With increasing investments in women’s health and the prioritisation of reproductive health services in national healthcare agendas, the market is positioned for sustained expansion in the coming years,” it added.